Transgender Men
5
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Evaluating Sexual Functioning in Trans Men During the Gender Affirmation Process: A Mixed Methods Study
HISTOLOGICAL RESULTS IN TRANSGENDER INDIVIDUALS ASSIGNED TO FEMALES AT BIRTH UNDERGOING GENDER AFFIRMATION SURGERY AND IN TESTOSTERONE THERAPY
Transmasculine Quality of Life and Sexual Function at Pre and Post Gender-affirming Hormonal Therapy
Transgender Men and HIV in Uganda: PrEP Uptake and Persistence
Mechanisms of Blood Pressure Dysfunction in Transmen Receiving Testosterone